ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the ...
Voya Financial, Inc. (NYSE: VOYA) announced today its third-quarter 2025 financial results: Net income available to common shareholders of $176 million, or $1.80 per diluted share. After-tax adjusted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback